RankingsPricing
  1. US-listed companies
  2. Profound Medical Corp.
  3. Raw

Profound Medical Corp.PROF

Market cap
$229.61M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2020		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net loss for the year-22-29-29-28
Depreciation---1
Amortization of Intangible Assets---0
Non-cash lease expense adjustment---0
Share-based compensation (note 11)---3
Interest And Accretion Expense---1
Change in Amortized Cost of Trade And Other Receivable----0
Trade and other receivables (note 3)----0
Inventory (note 4)----1
Prepaid expenses and deposits----0
Increase (Decrease) in Accounts Payable and Accrued Liabilities---1
Deferred revenue----1
Deferred tax liabilities (note 13)----0
Deferred tax assets (note 13)---0
Net cash used in operating activities----23
Issuance of commons shares (note 10)---62
Payments of financing costs (note 10)---5
Repayments of long-term debt (note 8)---3
Proceeds from Stock Options Exercised---0
Net cash provided by (used in) financing activities---55
Net increase (decrease) in cash and cash equivalents---31
Effect of exchange rate changes on cash----3
Income Taxes Paid, Net---0